Preclinical and clinical studies on CAR-NK cell therapy: latest update from 2025 ASH Annual Meeting
Abstract Chimeric antigen receptor–engineered natural killer (CAR-NK) cells are emerging as an off-the-shelf immunotherapy for hematologic malignancies, supported by early clinical data and a favorable safety profile. Compared with CAR-T therapy, CAR-NK cells offer the potential for scalable allogen...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2026-05-01
|
| coleção: | Experimental Hematology & Oncology |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s40164-026-00780-6 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|